Healthcare Needs of Sub-Saharan Africa’s Ageing Population

By Staff Writer

September 5, 2024

Introduction

The elderly population in sub-Saharan Africa is set to experience unprecedented growth. Projections indicate a rise from 50 million in 2020 to 150 million by 2050, and over 600 million by 2100. This rapid increase necessitates urgent attention to healthcare and public support systems. Despite the current unpreparedness, Sub-Saharan Africa has the potential for innovative policy responses. The National Bureau of Economic Research explores the healthcare challenges and opportunities for sub-Saharan Africa’s Ageing Population.

Current Policy Environment

Sub-Saharan Africa’s healthcare systems lag behind other regions. For example, only 13% of countries have high service coverage, while 26% have low service coverage. Life expectancy at age 60 is 18 years, compared to 20 years in other low- and middle-income countries (LMICs) and 24 years in high income countries (HICs). The region faces a “double-burden” of disease, with rising non-communicable diseases alongside persistent infectious diseases.

Public support programs are also lacking. Social protection expenditure on older persons averages around 1% of GDP, compared to 4% in other LMICs and 8% in HICs. Less than a quarter of the elderly population has pension coverage, compared to approximately half in other LMICs and near-universal coverage in HICs.

Figure1. Demographic Patterns in Selected Sub-Saharan African Countries

Healthcare Challenges

The healthcare needs of the elderly in Sub-Saharan Africa are complex. Older individuals often live in rural areas with limited access to healthcare facilities. Financial and non-financial barriers further hinder access. Stigma associated with conditions like dementia exacerbates these challenges. Women, in particular, suffer worse health outcomes in old age.

The healthcare systems are unprepared for the anticipated rise in non-communicable diseases. Many systems have experience treating infectious diseases but lack the infrastructure to manage chronic conditions. This gap must be addressed to improve health outcomes for the elderly.

Financial and Social Support

Family-based care systems have traditionally supported the elderly in Sub-Saharan Africa. However, these systems are under strain due to urban migration, declining fertility, and increased female labour force participation. Women are more likely to be unmarried and live alone in old age, increasing their risk of adverse health outcomes, financial insecurity, and social isolation.

Public support programs such as pensions and health insurance are essential. Governments must develop and expand these programs to reduce reliance on family-based care. Innovative solutions that incorporate familial and community involvement can help maintain psychological well-being.

Future Directions

Despite the current unpreparedness, there is an opportunity for effective policy design and implementation. Sub-Saharan Africa could benefit from a demographic dividend, with a growing working-age population reducing dependency ratios. This could free up resources for public programs.

Research is essential to inform policy. Data collection efforts should focus on high-quality, longitudinal datasets. Harmonisation with international studies will facilitate global comparisons. Context-specific measures of health care access, health outcomes, and financial security are necessary. Researchers should also explore the impact of education, human capital, and living standards on outcomes in old age.

Policies should address socioeconomic and gender-based inequalities. Older individuals in Sub-Saharan Africa are disproportionately exposed to poverty and deprivation. Lower-income and lower-education individuals exhibit higher mortality, greater disability, and lower quality of life. Women and unmarried individuals are particularly vulnerable. Policies must target the most vulnerable among the older population.

Conclusion

The rapid growth of the elderly population in Sub-Saharan Africa presents unique challenges and opportunities. Informal care systems are under threat from social and economic changes. However, positive economic growth and a demographic dividend could provide resources for innovative policymaking. Research and policy must focus on the needs of the elderly to ensure they receive adequate healthcare and support.

Reference url

Recent Posts

DTC telehealth partnerships
           

DTC Telehealth Partnerships: Navigating Risks in Pharma’s Digital Expansion

🚀 Are pharmaceutical companies’ DTC telehealth partnerships reshaping healthcare for better or worse?

Recent findings from the “DTC Investigation 2025” report reveal key insights into the high prescription rates and potential risks of these digital platforms operated by giants like Pfizer and Eli Lilly. Alarmingly, inadequate clinical safeguards raise questions about patient safety, prescribing practices, and cost implications.

Dive into this critical discussion about the intersection of digital health and pharmaceutical practices, and explore what it means for the future of patient care.

#SyenzaNews #DigitalHealth #HealthEconomics #HealthcarePolicy

MAF Test breast cancer
       

MAF Test Breast Cancer: Revolutionizing Personalized Treatment in Spanish Oncology

🌟 How can personalized medicine transform breast cancer treatment in Spain?

The recent rollout of the MAF Test breast cancer in leading Spanish hospitals is set to revolutionize patient care by enabling targeted treatment strategies. This innovative molecular assay not only identifies patients who will benefit from bisphosphonates but also spares those for whom the treatment may be harmful, ultimately improving outcomes for thousands.

Dive into the article to discover how this approach aligns with global trends in oncology and enhances healthcare resource allocation.

#SyenzaNews #precisionmedicine #HealthEconomics #innovation

ribociclib breast cancer guidance
           

NICE’s Ribociclib Breast Cancer Guidance: A New Era for High-Risk Patients in the NHS

🌟 Are we on the brink of transforming breast cancer treatment?

NICE’s latest guidance endorsing ribociclib in combination with an aromatase inhibitor marks a significant advancement for adults facing high-risk early breast cancer. This decision not only promises enhanced survival outcomes but also expands treatment options for patients historically limited to conventional therapies.

Dive into the details of this important development and learn how it may revolutionize patient care in the oncology landscape.

#SyenzaNews #oncology #costeffectiveness #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

JOIN NEWSLETTER

© 2025 Syenza™. All rights reserved.